Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050590

Expand all

TIMENTIN (CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM)
EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
Proprietary Name: TIMENTIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050590
Product Number: 001
Approval Date: Apr 1, 1985
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

TIMENTIN (CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM)
EQ 200MG BASE/VIAL;EQ 3GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
Proprietary Name: TIMENTIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 200MG BASE/VIAL;EQ 3GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050590
Product Number: 002
Approval Date: Apr 1, 1985
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

TIMENTIN (CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM)
EQ 1GM BASE/VIAL;EQ 30GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
Proprietary Name: TIMENTIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL;EQ 30GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050590
Product Number: 003
Approval Date: Aug 18, 1987
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information